Literature DB >> 8995564

Adenocarcinoma of the uterine cervix with predominantly villogladular papillary growth pattern.

T Kaku1, T Kamura, T Shigematsu, K Sakai, N Nakanami, K Uehira, S Amada, H Kobayashi, T Saito, H Nakano.   

Abstract

We reviewed the clinical and pathological features of seven cases of adenocarcinoma of the uterine cervix with predominantly villogladular papillary growth pattern. The patients, who ranged in age from 33 to 54 (mean, 45) years, underwent radical hysterectomy. In all seven cases, the tumors were papillary exophytic architecture lined by stratified epithelial cells with mild to moderate nuclear atypicality. In one of seven cases, the majority of the tumor showed villogladular papillary component, but the small foci of small cell carcinoma was present in the endocervical end of the tumor. The lymph vascular invasion was demonstrated in two of seven cases, and these two had pelvic lymph node metastases. One of these two patients had recurrence 30 months after the initial treatment and died of disease after 46 months. The follow-up ranged from 9 to 169 (median, 46) months. The presence or absence of lymph vascular invasion and minor components of this tumor such as small cell carcinoma, serous cell carcinoma, and clear cell carcinoma with a poor prognosis may be important histological findings before deciding to manage this tumor by the conservative treatment.

Entities:  

Mesh:

Year:  1997        PMID: 8995564     DOI: 10.1006/gyno.1996.4539

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  10 in total

1.  Well-differentiated papillary villoglandular adenocarcinoma of the uterine cervix with a focal high-grade component: is there a need for reassessment?

Authors:  Oluwole Fadare; Wenxin Zheng
Journal:  Virchows Arch       Date:  2005-08-09       Impact factor: 4.064

Review 2.  Recent advances in invasive adenocarcinoma of the cervix.

Authors:  Simona Stolnicu; Lien Hoang; Robert A Soslow
Journal:  Virchows Arch       Date:  2019-06-17       Impact factor: 4.064

3.  Villoglandular papillary adenocarcinoma of the uterine cervix: A report of 4 cases and a review of the literature.

Authors:  Qiang-Yong Zhou; Hai-Yan Chen; Si-Meng Yang; Yue-Hua Li; Xue-Qing Wu
Journal:  Oncol Lett       Date:  2015-11-18       Impact factor: 2.967

4.  A Case of Villoglandular Papillary Adenocarcinoma of the Uterine Cervix Diagnosed during Early Pregnancy Followed by Successful Term Delivery.

Authors:  Noriyuki Takai; Chihiro Hayashita; Satoru Nakamura; Hisashi Narahara; Hideo Matsumoto
Journal:  Case Rep Med       Date:  2010-06-10

5.  A retrospective review of 11 cases of villoglandular papillary adenocarcinoma of the uterine cervix and a review of the literature.

Authors:  Liping Zhao; Tianmin Xu; Manhua Cui; Zeming Fu
Journal:  Oncol Lett       Date:  2016-02-01       Impact factor: 2.967

6.  Villoglandular adenocarcinoma of cervix: pathologic features, clinical management, and outcome.

Authors:  Peng Guo; Pengfei Liu; Junjun Yang; Tong Ren; Yang Xiang
Journal:  Cancer Manag Res       Date:  2018-09-26       Impact factor: 3.989

Review 7.  Villoglandular adenocarcinoma of the uterine cervix: a systematic review and meta-analysis.

Authors:  Anna K Dietl; Matthias W Beckmann; Konrad Aumann
Journal:  Arch Gynecol Obstet       Date:  2021-05-25       Impact factor: 2.344

Review 8.  A Retrospective Study and Literature Review of Cervical Villoglandular Adenocarcinoma: A Candidate Paradigm of Silva System Pattern A.

Authors:  Yixuan Zhang; Yuxiang Wang; Yan Liu; Jing Yang; Congrong Liu
Journal:  Appl Immunohistochem Mol Morphol       Date:  2021-07-01

9.  Liquid-based cytology of villoglandular adenocarcinoma of the cervix: a report of 3 cases.

Authors:  Younghwa Choi; Haeryoung Kim; Haiyoung Choi; Daehyun Hwang; Gheeyoung Choe; Jin-Haeng Chung; So Yeon Park; Hye Seung Lee; Jin Ho Paik; Hyo Jin Park
Journal:  Korean J Pathol       Date:  2012-04-25

10.  Is the ovarian preservation safe in young women with stages IB-IIA villoglandular adenocarcinoma of the uterine cervix?

Authors:  U Chul Ju; Woo Dae Kang; Seok Mo Kim
Journal:  J Gynecol Oncol       Date:  2018-03-20       Impact factor: 4.401

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.